Congressional Republicans Call for Reconsideration of … – Ways and Means Republicans
WASHINGTON, DC Patients, caregivers, and practitioners will soon see fewer cures should the Biden Administration move forward with implementing its drug price-setting guidance, write House Ways and Means Chair Jason Smith (MO-08), House Energy and Commerce Chair Cathy McMorris Rodgers (WA-05), and U.S. Senator Mike Crapo (R-ID), Ranking Member of the Senate Finance Committee, in a letter to U.S. Health and Human Services Secretary Becerra and Centers for Medicare and Medicaid Services Administrator Brooks-LaSure.
The members note the guidance will deter product improvements for existing drugs, discourage public-private partnerships, weaken intellectual property protections and fail to provide stakeholders with adequate transparency.
From the letter:
We write to express disappointment and concern with recent implementation guidance for the drug price-setting provisions included in the Inflation Reduction Act (IRA, Pub. L. 117-169). This guidance exacerbates the laws statutory flaws and compounds the profound uncertainty and risk posed by the legislations sweeping drug price controls.
The Administrations guidance clearly values government power and overreach above precedent and statute, at the expense of patients seeking potentially life-saving treatments.
We urge you to work diligently and quickly to address these and other issues as you begin implementing this far-reaching new price control program. The preliminary decisions made through this initial guidance process, if carried out without greater reflection and input from the public, will have dire consequences for American patients for decades to come.
Read the full letter hereor below:
Dear Secretary Becerra and Administrator Brooks-LaSure:
We write to express disappointment and concern with recent implementation guidance for the drug price-setting provisions included in the Inflation Reduction Act (IRA, Pub. L. 117-169). This guidance exacerbates the laws statutory flaws and compounds the profound uncertainty and risk posed by the legislations sweeping drug price controls. We encourage you to reconsider the many components of the initial guidance that will otherwise stifle medical innovation and quality improvement, discourage proven public-private partnerships, undermine American intellectual property (IP) protections, and provide unacceptable conditions for public feedback. If finalized as proposed, these provisions will serve to make bad policy worse, harming patients, caregivers, and health care providers across the United States for generations to come.
The Administrations guidance clearly values government power and overreach above precedent and statute, at the expense of patients seeking potentially life-saving treatments. In an apparent effort to subject as many medications as possible to the IRAs price-setting program, the guidance uses an unusual definition of qualifying single-source drugs that aggregates entirely different medications according to their active ingredient or moiety, thereby discouraging research into future drug indications. This approach will blunt incentives for meaningful product improvements, in addition to punishing products that treat more than one disease.
The Centers for Medicare and Medicaid Services (CMS) misguided drug definition will chill efforts to mitigate side effects, improve adherence, bolster quality, and identify new uses and patient populations that might benefit from a given product. As outlined by Professor Erika Lietzan in a 2018 study, Development of new uses for already approved drugs, in particular, can make profound contributions to the public health.Another analysis, released that same year, details a lengthy list of examples along these lines, such as a failed attempt to a cancer drug repurposed decades later to become the first breakthrough in AIDS therapy.By reducing complex drugs and biologics to their active ingredients and collapsing new drug applications into a single product for price-setting purposes, the definition included in CMS guidance will decrease the likelihood of these types of groundbreaking developments moving forward. In light of this risk, we urge CMS to adopt a more conventional definition with a credible basis in the statute.
Even more alarmingly, this guidance appears to serve as a backdoor mechanism for achieving partisan policy goals, to the detriment of Americans health care. Specifically, the guidance treats federal financial support at any stage of drug discovery or development as grounds for further price manipulation by the Secretary under the program, resulting in a de facto expansion of so-called march-in authority, as referenced, but never imposed, under the Bayh-Dole Act. This effort comes despite consistent rejections, including by the Biden Administration, of attempts to rely on federal funding for a drug as grounds to impose price controls.In fact, the Bayh-Dole Acts bipartisan authors repeatedly affirmed that their framework aimed to incentivize public-private partnerships and accelerate access to meaningful medical innovations, rather than to discourage such collaborations or to punish innovators and research centers through pricing restrictions. The price-setting programs treatment of federal support risks undercutting private-sector interest in partnering with the government, further harming American patients.
Anti-innovation policymaking pervades the agencys initial guidance. Drugs with longer remaining patent terms or exclusivities, for instance, will see a downward adjustment in their Secretary-mandated prices, inverting the IP incentive structure that has driven most major inventions and breakthroughs since our nations founding. Research and development costs, meanwhile, would receive insufficient consideration during the price-setting process, with a narrow definition that ignores the complexities of drug development. In this way, CMS perpetuates a troubling pattern of mission creep, whereby the agency bypasses Congress and other federal departments to pursue goals outside of its jurisdiction.
In addition to these and other substantive policy concerns with the Administrations drug price-setting program, we also urge CMS to incorporate meaningful transparency and accountability into every stage of the new initiatives implementation. Already, we find the opportunity for public comment and its unduly brief response period leaving patients, caregivers, and other stakeholders inadequate time and opportunity to review and consider the vast new government rules and regulations at stake. CMS should provide longer comment periods and should not attempt to shield any portions of its regulatory proposals from public feedback or engagement. Furthermore, in implementing the price-setting program, the agency has an obligation to extend offers for additional meetings to hear feedback and input directly from those subjected to or otherwise affected by the process. For any number of conditions, from Alzheimers disease and cancer to the 95 percent of rare diseases that currently lack an approved treatment option, CMS must also ensure that patients can play a proactive and consistent role in the decision-making process.
Additionally, we have major concerns with the guidances severe limitations on basic due process protections, including for small businesses. The proposed policies would prohibit the disclosure of materials sent by the agency during the price-setting process, and manufacturers would ultimately need to destroy any such information, effectively undercutting the potential for the predictability, precedent, and stability that govern virtually all adjudication processes. When coupled with the laws broad restrictions on judicial and administrative review, these proposals stifle any opportunity for accountability, program integrity, or recourse for aggrieved parties.
We urge you to work diligently and quickly to address these and other issues as you begin implementing this far-reaching new price control program. The preliminary decisions made through this initial guidance process, if carried out without greater reflection and input from the public, will have dire consequences for American patients for decades to come.
If you have questions about this request, please contact Conor Sheehey of the Senate Finance Committee staff, Alec Aramanda of the House Committee on Energy and Commerce, and Patrick Dumas of the House Committee on Ways and Means.
Sincerely,
Read the rest here:
Congressional Republicans Call for Reconsideration of ... - Ways and Means Republicans
- Senate Republicans Block Bid to Rein in Trump on Iran War - The New York Times - November 19th, 2026 [November 19th, 2026]
- The midterms were bad for Republicans. The closest races show how it was nearly even worse. - NBC News - November 19th, 2026 [November 19th, 2026]
- Senate Republicans rejects war powers bill to halt fighting in Iran - The Guardian - November 19th, 2026 [November 19th, 2026]
- Episode 84: What Should Republicans and Democrats be Thankful For? w/ CNNs Phil Mattingly - Inside Elections - November 19th, 2026 [November 19th, 2026]
- Wisconsin Republicans prepare for first legislative minority since 2010 - Spectrum News - November 19th, 2026 [November 19th, 2026]
- House Republicans Introduce Four Bills for DHS, CISA to Address AI Cyberthreats - ExecutiveGov - November 19th, 2026 [November 19th, 2026]
- Republicans scramble to help Trump loyalist tapped to lead Congress watchdog agency - MS NOW - November 19th, 2026 [November 19th, 2026]
- California Republicans won only four of states 52 US House seats in midterms - The Guardian - November 19th, 2026 [November 19th, 2026]
- Hanaway: Republicans have to care about the electorate - FOX 2 - November 19th, 2026 [November 19th, 2026]
- Somali Republicans in Minnesota voted against the party over rhetoric, policy - Eden Prairie Local News - November 19th, 2026 [November 19th, 2026]
- Ohio Republicans expand concealed and carry rights while easing rules on loaded weapons in vehicles - WKYC - November 19th, 2026 [November 19th, 2026]
- Backing Trump, US Senate Republicans block Iran war resolution - The Times of Israel - November 19th, 2026 [November 19th, 2026]
- Senate Republicans block latest Democratic effort to end the war in Iran - The Seattle Times - November 19th, 2026 [November 19th, 2026]
- Senate Republicans see no need to oust Duffy, Bedford - Politico - November 19th, 2026 [November 19th, 2026]
- Incoming Rep. Constantino isnt looking to make friends. What are Republicans to do? - NCPR: North Country Public Radio - November 19th, 2026 [November 19th, 2026]
- Dems look to dismantle major Trump program. And Republicans could be ready to help - SILive.com - November 19th, 2026 [November 19th, 2026]
- Two Republicans face off for top spot on House committee left open by Alabamas Mike Rogers - Washington Examiner - November 19th, 2026 [November 19th, 2026]
- Ohio Republicans trying to restrict abortion again - News 5 Cleveland WEWS - November 19th, 2026 [November 19th, 2026]
- The Republicans Next Coalition: What Kind Can They Form? - National Review - November 19th, 2026 [November 19th, 2026]
- Senate Republicans block latest Democratic effort to end the war in Iran - WPXI - November 19th, 2026 [November 19th, 2026]
- House Republicans threaten to ax defense bills Ukraine provisions in effort to block stronger Pentagon oversight - NBC News - November 17th, 2026 [November 17th, 2026]
- Republicans outspent Democrats for first time in over a decade in record 2026 midterm election political ad blitz - CNBC - November 17th, 2026 [November 17th, 2026]
- Its a horrible idea: Republicans shut down talk of Jensen Huangs return - Politico - November 17th, 2026 [November 17th, 2026]
- Brooks and Marcus on how Republicans are responding to midterm losses - PBS - November 17th, 2026 [November 17th, 2026]
- Texas Democrats have started laying out their agenda. Where might Republicans draw the line? - Houston Public Media - November 17th, 2026 [November 17th, 2026]
- ICE may have cost Republicans more votes than inflation did in 2026 - Strength In Numbers | G. Elliott Morris - November 17th, 2026 [November 17th, 2026]
- Here are the Republicans emerging as potential 2028 contenders - Reuters - November 17th, 2026 [November 17th, 2026]
- Did the Redistricting Wars Backfire on Republicans? In a Word, No. - The New York Times - November 17th, 2026 [November 17th, 2026]
- Democrats win control of the Texas House from Republicans after remaining "cautiously optimistic" - CBS News - November 17th, 2026 [November 17th, 2026]
- Rep. Tittl Says Work Will Get Done With Republicans In The Minority - Seehafer News - November 17th, 2026 [November 17th, 2026]
- Maryland Senate Republicans stick with Hershey and Ready as leaders - Baltimore Sun - November 17th, 2026 [November 17th, 2026]
- Senate Republicans return to Capitol furious with Trump after big losses - The Hill - November 9th, 2026 [November 9th, 2026]
- On 60 Minutes, Trump Says Immigration Crackdown May Have Hurt Republicans in Elections - The New York Times - November 9th, 2026 [November 9th, 2026]
- After losing Congress, Republicans have one last shot to pass their agenda - The Detroit News - November 9th, 2026 [November 9th, 2026]
- The fight over Republicans future has begun - The Economist - November 9th, 2026 [November 9th, 2026]
- Missouri Republicans mulling future of congressional redistricting after Prop A failure - STLPR - November 9th, 2026 [November 9th, 2026]
- Opinion | Jetton: Republicans Fought Each Other and Stopped Talking to Voters. Missouri Noticed. - The Missouri Times - - November 9th, 2026 [November 9th, 2026]
- Defeated Republicans Return to Washington With 55 Days Left and a Long Wish List - WSJ - November 9th, 2026 [November 9th, 2026]
- Opinion | Democrats won the midterms. Republicans may have won something bigger. - The Washington Post - November 9th, 2026 [November 9th, 2026]
- After losing Congress, Republicans have one last shot to pass their agenda - The Washington Post - November 9th, 2026 [November 9th, 2026]
- The midterms blew open the 2028 map. Republicans are panicking. - Politico - November 9th, 2026 [November 9th, 2026]
- Trump targets Slotkin in call for DOJ probe of alleged Democratic threats to Republicans - CNBC - November 9th, 2026 [November 9th, 2026]
- Republicans Point Fingers, but Trump Does Not Appear to Be Listening - The New York Times - November 9th, 2026 [November 9th, 2026]
- Florida Republicans survived the blue wave, but find themselves on shaky ground - The Guardian - November 9th, 2026 [November 9th, 2026]
- Trumps grip on his party is in question as Republicans reel from the midterm wipeout - AP News - November 9th, 2026 [November 9th, 2026]
- Trump: Republicans did poorly in midterms because of a great dislike, incredibly, for Israel - The Times of Israel - November 9th, 2026 [November 9th, 2026]
- Republicans rammed through Supreme Court nominees. Now Democrats will have the votes to stop them - Arkansas Advocate - November 9th, 2026 [November 9th, 2026]
- 'This is a disaster': Angry Republicans blame Trump for midterms defeat - BBC - November 9th, 2026 [November 9th, 2026]
- Meet the Contenders to Lead House Republicans in the Wilderness - Bloomberg Government News - November 9th, 2026 [November 9th, 2026]
- Letter: Election sends clear message to Republicans - Honolulu Star-Advertiser - November 9th, 2026 [November 9th, 2026]
- Missourians Rejected Another Abortion Ban. Republicans Say Theyre Not Giving Up Yet. - Rewire News Group - November 9th, 2026 [November 9th, 2026]
- Opinion | Republicans Got Ruinously High on Their Own Supply - The New York Times - November 9th, 2026 [November 9th, 2026]
- Republicans were punished in the midterms for Trump's economic policies, The AP Voter Poll shows - Arkansas Advocate - November 9th, 2026 [November 9th, 2026]
- Trump defends Jensen Huang, but other Republicans could turn up the pressure quickly - Yahoo Finance - November 9th, 2026 [November 9th, 2026]
- Republicans maintained their majority in the general election for Ohio House of Representatives on Nov. 3 - Ballotpedia News - November 9th, 2026 [November 9th, 2026]
- Two House Republicans battle to lead the partys diminished ranks - The Washington Post - November 9th, 2026 [November 9th, 2026]
- The Midterms Were Bad for Republicans. 2028 Is Going to Be Even Worse. - The New Republic - November 9th, 2026 [November 9th, 2026]
- Former House Speaker McCarthy on midterm election results: 'This is a wake up call for Republicans' - CNBC - November 9th, 2026 [November 9th, 2026]
- GV dems and republicans host watch party for midterm elections - Grand Valley Lanthorn - November 9th, 2026 [November 9th, 2026]
- Paxton Hits the Road, Looking to Rally Texas Republicans - The New York Times - October 17th, 2026 [October 17th, 2026]
- The Senate Race Republicans Never Expected to Sweat - WSJ - October 17th, 2026 [October 17th, 2026]
- Whats missing at No Kings? The Republicans who say theyre fed up with Trump. - MS NOW - October 17th, 2026 [October 17th, 2026]
- Republicans break away from Trump on foreign policy as Midterms near - WCAX - October 17th, 2026 [October 17th, 2026]
- FBI arrests CT man accused of threatening Republicans - CT Mirror - October 17th, 2026 [October 17th, 2026]
- Republicans have a huge fundraising advantage. Will it matter? - Vox - October 17th, 2026 [October 17th, 2026]
- Senate Republicans are getting smoked in fundraising - Politico - October 17th, 2026 [October 17th, 2026]
- Republicans can confirm a Supreme Court justice if Democrats take the Senate, but at what cost? - The Conversation - October 17th, 2026 [October 17th, 2026]
- Some Republicans in key races break with Trump over tariffs - NBC News - October 17th, 2026 [October 17th, 2026]
- Trump urges supporters to pretend hes on the ballot as he campaigns with Georgia Republicans - Georgia Recorder - October 17th, 2026 [October 17th, 2026]
- Trump promises big investment in KY facility 'if the Republicans win' - The Courier-Journal - October 17th, 2026 [October 17th, 2026]
- Republicans shift funds in the battle for the House, pulling money from some tough races - NBC News - October 17th, 2026 [October 17th, 2026]
- Michigan elections: What Democrats, Republicans say theyd do if they win big - Bridge Michigan - October 17th, 2026 [October 17th, 2026]
- Republicans are throwing money at this tossup California district. Should the Democrat worry? - CalMatters - October 17th, 2026 [October 17th, 2026]
- Republicans break away from Trump on foreign policy as Midterms near - WLFI - October 17th, 2026 [October 17th, 2026]
- Republicans need to learn the Democrats bitter lesson of 2022 - The Economist - October 17th, 2026 [October 17th, 2026]
- Republicans are playing defense and its costing them - CNN - October 17th, 2026 [October 17th, 2026]
- A trader just placed a $16K bet against Republicans winning the Texas Senate race in 2026 - Quiver Quantitative - October 17th, 2026 [October 17th, 2026]
- A trader just placed a $32K bet against Republicans winning the Ohio Senate race in 2026 - Quiver Quantitative - October 17th, 2026 [October 17th, 2026]
- If Republicans get crushed in the midterms, what's their plan B? | Opinion - USA Today - October 13th, 2026 [October 13th, 2026]
- 5 House districts where Republicans are looking to turn the tables as Democrats eye big midterm wins - PBS - October 13th, 2026 [October 13th, 2026]